Monitoring of CD38high expression in peripheral blood CD8+ lymphocytes in patients after kidney transplantation as a marker of cytomegalovirus infection

Transplant Immunology

Volumn 24, Issue 1, 2010, Pages 50-56

  Ticha, Olga ^a   Stouracova, Martina ^a   Kuman, Milan ^b   Studenik, Pavel ^b   Freiberger, Tomas ^b   Litzman, Jiri ^a  

^a ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^b Centre for Cardiovascular Surgery and Transplantation   (Czech Republic)

Author keywords

CD38; Cytomegalovirus; Kidney transplant

Indexed keywords

ACICLOVIR; CD3 ANTIGEN; CD38 ANTIGEN; CD8 ANTIGEN; CYCLOSPORIN A; GANCICLOVIR; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR; VIRUS DNA; BIOLOGICAL MARKER;

ADULT; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DIAGNOSTIC VALUE; FEMALE; FLOW CYTOMETRY; HIGH RISK PATIENT; HUMAN; IMMUNOLOGICAL MONITORING; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; PERIPHERAL LYMPHOCYTE; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; BIOSYNTHESIS; CYTOMEGALOVIRUS; GRAFT REJECTION; IMMUNOLOGY; METABOLISM; METHODOLOGY; MIDDLE AGED; MONITORING; PATHOGENICITY; PATHOLOGY; PHYSIOLOGY; PREDICTIVE VALUE;

ADULT; ANTIGENS, CD38; BIOLOGICAL MARKERS; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GRAFT REJECTION; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 78449238818     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2010.10.002     Document Type: Article

References (44)

1. Hecker M., Qiu D., Marquardt K., Bein G., Hackstein H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang 2004, 86:41-44.
2. Staras S., Dollard S., Radford K., Flanders W., Pass R., Cannon M. Seroprevalence of cytomegalovirus infection in the United States, 1988-1994. Clin Infect Dis 2006, 43:1143-1151.
3. Munro S., Hall B., Whybin L., Leader L., Robertson P., Maine G.T., et al. Diagnosis of and screening for cytomegalovirus infection in pregnant women. J Clin Microbiol 2005, 43:4713-4718.
4. Rubin R. Cytomegalovirus in solid organ transplantation. Transpl Infect Dis 2001, 3(Suppl. 2):1-5.
5. Razonable R., Emery V. Management of CMV infection and disease in transplant patients. Herpes 2004, 11:77-86.
6. Patel R., Paya C. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997, 10:86-124.
7. Radha R., Jordan S., Puliyanda D., Bunnapradist S., Petrosyan A., Amet N., et al. Cellular immune responses to cytomegalovirus in renal transplant recipients. Am J Transplant 2005, 5:110-117.
8. Sagedal S., Nordal K., Hartmann A., Sund S., Scott H., Degré M., et al. The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients. Am J Transplant 2002, 2:850-856.
9. Streblow D., Orloff S., Nelson J. Acceleration of allograft failure by cytomegalovirus. Curr Opin Immunol 2007, 19:577-582.
10. Razonable R., Paya C. Infections and allograft rejection: Intertwined complications of organ transplantation. Swiss Med Wkly 2005, 135:571-573.
11. Paya C. Indirect effects of CMV in the solid organ transplant patient. Transpl Infect Dis 1999, 1(Suppl 1):8-12.
12. Legendre C., Pascual M. Improving outcomes for solid-organ transplant recipients at risk from cytomegalovirus infection: Late-onset disease and indirect consequences. Clin Infect Dis 2008, 46:732-740.
13. Fishman J., Emery V., Freeman R., Pascual M., Rostaing L., Schlitt H.J., et al. Cytomegalovirus in transplantation: Challenging the status quo. Clin Transplant 2007, 21:149-158.
14. Boeckh M., Boivin G. Quantitation of cytomegalovirus: Methodologic aspects and clinical applications. Clin Microbiol Rev 1998, 11:533-554.
15. Sia I., Patel R. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients. Clin Microbiol Rev 2000, 13:83-121.
16. Baldanti F., Lilleri D., Gerna G. Monitoring human cytomegalovirus infection in transplant recipients. J Clin Virol 2008, 41:237-241.
17. Funaro A., Spagnoli G., Ausiello C., Alessio M., Roggero S., Delia D., et al. Involvement of the multilineage CD38 molecule in a unique pathway of cell activation and proliferation. J Immunol 1990, 145:2390-2396.
18. Mehta K., Shahid U., Malavasi F. Human CD38: A cell-surface protein with multiple functions. FASEB J 1996, 10:1408-1417.
19. Malavasi F., Funaro A., Roggero S., Horenstein A., Calosso L., Mehta K. Human CD38: A glycoprotein in search of a function. Immunol Today 1994, 15:95-97.
20. Van Lier R., ten Berge I., Gamadia L. Human CD8(+) T-cell differentiation in response to viruses. Nat Rev Immunol 2003, 3:931-939.
21. Callan M., Tan L., Annels N., Wilson J.D., O'Callaghan C.A., Steven N., et al. Direct visualization of antigen-specific CD8+ T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med 1998, 187:1395-1402.
22. Zidovec Lepej S., Vince A., Dakovic Rode O., Remenar A., Jeren T. Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol 2003, 133:384-390.
23. Glencross D., Janossy G., Coetzee L., Lawrie D., Scott L.E., Sanne I., et al. CD8/CD38 activation yields important clinical information of effective antiretroviral therapy: Findings from the first year of the CIPRA-SA cohort. Cytometry B Clin Cytom 2008, 74(Suppl 1):131-140.
24. Almeida M., Cordero M., Almeida J., Orfao A. Relationship between CD38 expression on peripheral blood T-cells and monocytes, and response to antiretroviral therapy: A one-year longitudinal study of a cohort of chronically infected ART-naive HIV-1+ patients. Cytometry B Clin Cytom 2007, 72:22-33.
25. Giorgi J., Hultin L., McKeating J., Johnson T.D., Owens B., Jacobson L.P., et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999, 179:859-870.
26. Appay V., Papagno L., Spina C., Hansasuta P., King A., Jones L., et al. Dynamics of T cell responses in HIV infection. J Immunol 2002, 168:3660-3666.
27. Tilling R., Kinloch S., Goh L., Cooper D., Perrin L., Lampe F., et al. Parallel decline of CD8+/CD38++ T cells and viraemia in response to quadruple highly active antiretroviral therapy in primary HIV infection. AIDS 2002, 16:589-596.
28. Mocroft A., Bofill M., Lipman M., Medina E., Borthwick N., Timms A., et al. CD8+, CD38+ lymphocyte percent: A useful immunological marker for monitoring HIV-1-infected patients. J Acquir Immune Defic Syndr Hum Retrovirol 1997, 14:158-162.
29. Belles-Isles M., Houde I., Lachance J., Noël R., Kingma I., Roy R. Monitoring of cytomegalovirus infections by the CD8+CD38+T-cell subset in kidney transplant recipients. Transplantation 1998, 65:279-282.
30. Wang Y., Liu Y., Han R., Li Q., Yao Z., Niu W., et al. Monitoring of CD95 and CD38 expression in peripheral blood T lymphocytes during active human cytomegalovirus infection after orthotopic liver transplantation. J Gastroenterol Hepatol 2010, 25:138-142.
31. Boleslawski E., BenOthman S., Grabar S., Correia L., Podevin P., Chouzenoux S., et al. CD25, CD28 and CD38 expression in peripheral blood lymphocytes as a tool to predict acute rejection after liver transplantation. Clin Transplant 2008, 22:494-501.
32. Perrella O., Sbreglia C., Arenga G., Perrella A., Ferrara A., D'Antonio A., et al. Acute rejection after liver transplantation: Is there a specific immunological pattern?. Transplant Proc 2006, 38:3594-3596.
33. Li H., Dummer J.S., Estes W.R., Meng S., Wright P.F., Tang Y.W. Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol 2003, 41:187-191.
34. Drew W. Laboratory diagnosis of cytomegalovirus infection and disease in immunocompromised patients. Curr Opin Infect Dis 2007, 20:408-411.
35. Eid A.J., Razonable R.R. Cytomegalovirus disease in solid organ transplant recipients: Advances lead to new challenges and opportunities. Curr Opin Organ Transplant 2007, 12:610-617.
36. Ljungman P., Griffiths P., Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis 2002, 34:1094-1097.
37. Ruell J., Barnes C., Mutton K., Foulkes B., Chang J., Cavet J., et al. Active CMV disease does not always correlate with viral load detection. Bone Marrow Transplant 2007, 40:55-61.
38. Taherimahmoudi M., Ahmadi H., Baradaran N., Montaser-Kouhsari L., Salem S., Mehrsai A., et al. Cytomegalovirus infection and disease following renal transplantation: Preliminary report of incidence and potential risk factors. Transplant Proc 2009, 41:2841-2844.
39. Siu C., Chan T., Li F., Choy B.Y., Lui S.L., Lo C.Y., et al. Association between anti-thymocyte globulin administration and cytomegalic virus infection and/or CMV disease in cadaveric renal allograft recipients. Transplant Proc 2000, 32:1932-1934.
40. Abecassis M., Koffron A., Buckingham M., Kaufman D.B., Fryer J.P., Stuart J., et al. Role of PCR in the diagnosis and management of CMV in solid organ recipients: What is the predictive value for development of disease and should PCR be used to guide antiviral therapy?. Transplant Proc 1997, 29:800-801.
41. Emery V., Cope A., Sabin C., Burroughs A.K., Rolles K., Lazzarotto T., et al. Relationship between IgM antibody to human cytomegalovirus, virus load, donor and recipient serostatus, and administration of methylprednisolone as risk factors for cytomegalovirus disease after liver transplantation. J Infect Dis 2000, 182:1610-1615.
42. Sola R., Rabella N., Guirado L.L., Díaz J.M., Facundo C., García R. Relation between pp 65 antigenemia, RT-PCR and viruria for cytomegalovirus detection in kidney transplant recipients. Transplant Proc 2005, 37:3768-3769.
43. Kalil A., Levitsky J., Lyden E., Stoner J., Freifeld A. Meta-analysis: The efficacy of strategies to prevent organ disease by cytomegalovirus in solid organ transplant recipients. Ann Intern Med 2005, 143:870-880.
44. Small L., Lau J., Snydman D. Preventing post-organ transplantation cytomegalovirus disease with ganciclovir: A meta-analysis comparing prophylactic and preemptive therapies. Clin Infect Dis 2006, 43:869-880.